Therapeutic Asset Ratings
204 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
asn51
Alzheimer Disease
Asceneuron S.A.
P2
CCC
(51)
Astragalus Membranaceus Root
Alzheimer Disease
Fujian Medical University Union Hospital
P2
CCC
(51)
Benfotiamine
Alzheimer Disease
Alzheimer's Disease Cooperative Study (ADCS)
P2
CCC
(51)
Empagliflozin
Alzheimer Disease
Wake Forest University Health Sciences
P2
CCC
(51)
ly3372689
Alzheimer Disease
Eli Lilly and Company
P2
CCC
(51)
Mevidalen
Alzheimer Disease
Eli Lilly and Company
P2
CCC
(51)
mk-1167
Alzheimer Disease
Merck Sharp & Dohme LLC
P2
CCC
(51)
rem0046127
Alzheimer Disease
reMYND
P2
CCC
(51)
tw001
Alzheimer Disease
Treeway B.V.
P2
CCC
(51)
Bxcl501
Alzheimer Disease
Applied Cognition
P1/2
CCC
(49)
lx1001
Alzheimer Disease
Lexeo Therapeutics
P1/2
CCC
(49)
5-Hexenamide, 6-(3,4-dimethoxyphenyl)-3-[(2E)-3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-N,N-diethyl-3-methyl-4-oxo-, (5E)-
Alzheimer Disease
Merry Life Biomedical Co., Ltd.
P2
CCC
(48)
7-ISOPROPOXYISOFLAVONE
Alzheimer Disease
Massachusetts General Hospital
P2
CCC
(48)
Amdx-2011P
Alzheimer Disease
Amydis Inc.
P2
CCC
(48)
Astragalus
Alzheimer Disease
Fujian Medical University Union Hospital
P2
CCC
(48)
BMS-986368
Alzheimer Disease
Celgene
P2
CCC
(48)
Bumetanide
Alzheimer Disease
Stanford University
P2
CCC
(48)
Calcipotriene
Alzheimer Disease
Rune Skovgaard Rasmussen
P2
CCC
(48)
Cort108297
Alzheimer Disease
Johns Hopkins University
P2
CCC
(48)
ex039
Alzheimer Disease
Excelsior
P2
CCC
(48)
Explas
Alzheimer Disease
Norwegian University of Science and Technology
P2
CCC
(48)
FEOBV F-18
Alzheimer Disease
Vanderbilt University Medical Center
P2
CCC
(48)
FLUTICASONE
Alzheimer Disease
University of Colorado, Denver
P2
CCC
(48)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Alzheimer Disease
Novartis Pharmaceuticals
P2
CCC
(48)
Jnj-64042056
Alzheimer Disease
Janssen Pharmaceutica N.V., Belgium
P2
CCC
(48)
Showing 76 to 100 of 204 assets
Previous
Page 4 of 9
Next